Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2010 | 2 |
2015 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
[Kind-Philipp Symposium in honor to the trustor Dr.-Ing. Walter Reiners and Kind-Philipp Award 2008].
Klin Padiatr. 2009 Nov-Dec;221(6):327-31. doi: 10.1055/s-0029-1239505. Epub 2009 Nov 4.
Klin Padiatr. 2009.
PMID: 19890782
German.
No abstract available.
Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.
Vrachimis A, Wenning C, Gerß J, Dralle H, Vaez Tabassi M, Schober O, Riemann B; MSDS study group.
Vrachimis A, et al.
J Surg Oncol. 2015 Jul;112(1):9-14. doi: 10.1002/jso.23948. Epub 2015 Jun 12.
J Surg Oncol. 2015.
PMID: 26074402
Clinical Trial.
Item in Clipboard
Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial.
Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O; MSDS study group.
Biermann M, et al.
Nuklearmedizin. 2009;48(3):89-98; quiz N15. doi: 10.3413/nukmed-0221. Epub 2009 Mar 23.
Nuklearmedizin. 2009.
PMID: 19322503
Clinical Trial.
Item in Clipboard
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial.
Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Lerch H, Gerss J, Frankewitsch T, Schober O, Riemann B; MSDS study group.
Krämer JA, et al.
Eur J Endocrinol. 2010 Oct;163(4):637-44. doi: 10.1530/EJE-10-0116. Epub 2010 Jul 21.
Eur J Endocrinol. 2010.
PMID: 20660003
Clinical Trial.
Item in Clipboard
Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.
Riemann B, Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Sauerland C, Frankewitsch T, Schober O; MSDS study group.
Riemann B, et al.
Nuklearmedizin. 2010;49(3):79-84. doi: 10.3413/nukmed-0302.
Nuklearmedizin. 2010.
PMID: 20505894
Item in Clipboard
Cite
Cite